Monocyte chemoattractant protein-2 is a potent agonist of CCR2B
Cellular and Molecular Mechanisms of Host Defense and Inflammation

Authors: Moore, U. M., Kaplow, J. M., Pleass, R. D., Castro, S. W., Naik, K., Lynch, C. N., Daly, S., Roach, A. G., Jaye, M., Williams, R. J.

Source: JOURNAL OF LEUKOCYTE BIOLOGY. 62(6):911-915

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN036645519&indx=1&recIds=ETOCRN036645519

Microglial involvement and amyloid reduction with BAN2401/mAb158, a monoclonal antibody with high selectivity for protofibrils: In vitro and ex vivo analyses

Authors: Kaplow, J. M., Kusnetov, G., Mastroeni, D., Navia, B., Kumar, N., Biscaro, B., Koyama, A., Möller, C., Lai, R., Swanson, C.

Source: ALZHEIMERS AND DEMENTIA. 9(4):P807-P808

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN341220189&indx=1&recIds=ETOCRN341220189

Initial learnings from screening strategies in the BAN 2401-G000-201 trial: An early Alzheimer's disease study

Authors: Logovinsky, V., Swanson, C., Lai, R., Do, I., Kaplow, J. M., Rabe, M. P., Gordon, R., Wang, J., Xu, L., Basun, H.

Source: ALZHEIMERS AND DEMENTIA. 10(4):P855-P855

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN359665555&indx=1&recIds=ETOCRN359665555

Consideration for â€Åâ€Å'early Alzheimer's disease (AD)� trials with a single prodromal AD and mild AD dementia population: ADNI data analysis and initial observations from the BAN2401-G000-201 trial

Authors: Swanson, C. J., Logovinsky, V., Xu, L., Wang, J., Lai, R., Rabe, M. P., Gordon, R., Kaplow, J. M., Basun, H., Lannfelt, L.

Source: ALZHEIMERS AND DEMENTIA. 10(4):P778-P778

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN359663625&indx=1&recIds=ETOCRN359663625

Clinical study of E2609, a novel BACE1 inhibitor, demonstrates target engagement and inhibition of BACE1 activity in CSF

Authors: Bernier, F., Sato, Y., Matijevic, M., Desmond, H., McGrath, S., Burns, L., Kaplow, J. M., Albala, B.

Source: ALZHEIMERS AND DEMENTIA. 9(4):P886-P886

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN341222216&indx=1&recIds=ETOCRN341222216

Pharmacology of BAN2401: A monoclonal antibody selective for beta-amyloid protofibrils

Authors: Swanson, C., Kaplow, J. M., Mastroeni, D., Rogers, J., Waara, E. R., Navia, B., Lai, R., Logovinsky, V., Möller, C., Lannfelt, L.

Source: ALZHEIMERS AND DEMENTIA. 9(4):P809-P809

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN341220220&indx=1&recIds=ETOCRN341220220

A multimodal imaging study of mAb158, a murine monoclonal antibody with high selectivity for amyloid protofibrils, in Tg2576 mice

Authors: Navia, B., Perdomo, C., Krause, S., Kaplow, J. M., Koyama, A., Teceno, T., Gershman, B., Logovinsky, V., Swanson, C., Lai, R.

Source: ALZHEIMERS AND DEMENTIA. 9(4):P808-P808

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN341220190&indx=1&recIds=ETOCRN341220190

A first-in-human study of BAN2401, a novel monoclonal antibody against beta-amyloid protofibrils

Authors: Lai, R., Logovinsky, V., Kaplow, J. M., Gu, K., Yu, Y., Möller, C., Navia, B., Swanson, C., Lannfelt, L., Satlin, A.

Source: ALZHEIMERS AND DEMENTIA. 9(4):P689-P689

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN341217026&indx=1&recIds=ETOCRN341217026

Soluble BACE activity and sAPPβ levels do not differentiate Alzheimer's disease and age-matched control cerebrospinal fluid in the ADNI-1 cohort

Authors: Savage, M., Holder, D., Wu, G., Kaplow, J. M., Siuciak, J., Potter, W.

Source: ALZHEIMERS AND DEMENTIA. 9(4):P201-P201

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN341204614&indx=1&recIds=ETOCRN341204614

First-in-human study of E2609, a novel BACE1 inhibitor, demonstrates prolonged reductions in plasma beta-amyloid levels after single dosing

Authors: Lai, R., Albala, B., Kaplow, J. M., Aluri, J., Yen, M., Satlin, A.

Source: ALZHEIMERS AND DEMENTIA. 8(4):P96-P96

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN315784887&indx=1&recIds=ETOCRN315784887

Cloning and expression of two distinct high‐affinity receptors cross‐reacting with acidic and basic fibroblast growth factors.

Authors: Dionne, C. A., Crumley, G., Bellot, F., Kaplow, J. M., Searfoss, G., Ruta, M., Burgess, W. H., Jaye, M., Schlessinger, J.

Source: The EMBO Journal; September 1990, Vol. 9 Issue: 9 p2685-2692, 8p